Sort
30,917 grants matching “tumor microenvironment”
Skin Stem Cells: Purification and Characterization
$372,900Elaine Fuchs · Rockefeller University · R01 · FY2020 · AR
Tumor-Targeted Chemo-Immunotherapy for Osteosarcoma Metastasis
$372,888Liangfang Zhang · University Of California, San Diego · R01 · FY2016 · CA
Improved therapy for p53wt melanoma by functionally restoring the CDKN2A pathway
$372,875Ann Richmond · Vanderbilt University · R01 · FY2017 · CA
Improved therapy for p53wt melanoma by functionally restoring the CDKN2A pathway
$372,875Ann Richmond · Vanderbilt University · R01 · FY2015 · CA
Improved therapy for p53wt melanoma by functionally restoring the CDKN2A pathway
$372,875Ann Richmond · Vanderbilt University · R01 · FY2018 · CA
Improved therapy for p53wt melanoma by functionally restoring the CDKN2A pathway
$372,875Ann Richmond · Vanderbilt University · R01 · FY2016 · CA
Project 2: Spatial Architecture of Tumor-Mediated Immunosuppression
$372,870Garry P Nolan · Stanford University · U54 · FY2020 · CA
Correlates of antitumor immunity in colorectal cancers and anti PD1 therapy
$372,863Franck Housseau · Johns Hopkins University · R01 · FY2016 · CA
Human mast cells as a platform for new cancer immunotherapy strategies
$372,846Chris L Kepley · Liberty University, Inc. · R15 · FY2023 · CA
Tumor cell instrinsic DNA damage signaling to the immune response
$372,839Roger A Greenberg · University Of Pennsylvania · P01 · FY2025 · CA
Tumor Cell-Microenvironment Interactions in the Molecular Pathogenesis of Multipl
$372,828John Damian Shaughnessy · Univ Of Arkansas For Med Scis · P01 · FY2013 · CA
Initiation and Evolution of the Ovarian Cancer Microenvironment
$372,820Jose R Conejo-Garcia · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2017 · CA
Project 1: Organismal Evolution
$372,812Carlo C Maley · Arizona State University-Tempe Campus · U54 · FY2018 · CA
Project 3: Neoplastic Cell Evolution
$372,812Darryl K Shibata · Arizona State University-Tempe Campus · U54 · FY2018 · CA
Proteomic, Glycomic and Autoantibody Lung Cancer Biomarker Validation
$372,766Paul D Lampe · Fred Hutchinson Cancer Research Center · U01 · FY2016 · CA
CANCAN - SALK
$372,748Janelle S Ayres · Salk Institute For Biological Studies · OT2 · FY2024 · CA
Non-genomic resistance mechanisms in EGFR-mutant lung cancer
$372,721Aaron N Hata · Massachusetts General Hospital · R01 · FY2024 · CA
Targeting MUC1-induced Tumor-stromal Metabolic Cross-talk in Pancreatic Cancer
$372,693Pankaj Kumar Singh · University Of Nebraska Medical Center · R01 · FY2015 · CA
Amoeboid Membrane Dynamics in Prostate Cancer
$372,685Michael R Freeman · Cedars-Sinai Medical Center · R01 · FY2013 · CA
(PQ1) Epigenetic effects of the premalignant field
$372,671Lance S Terada · Ut Southwestern Medical Center · R01 · FY2017 · CA
New Strategies for Treatment of NRAS Mutant Melanoma after Progression on Immune Checkpoint Inhibitors
$372,669Ann Richmond · Vanderbilt University · R01 · FY2022 · CA
Spatiomolecular Profiling of Human Cancer at Scale
$372,628Nicolas Chevrier · University Of Chicago · R33 · FY2025 · CA
Functional Dissection of Metabolic-Sensing Proline Hydroxylation Pathways
$372,623Yue Chen · University Of Minnesota · R35 · FY2018 · GM
Interleukin-35 and the tumor microenvironment
$372,595Dario Aa Vignali · University Of Pittsburgh At Pittsburgh · R01 · FY2016 · CA
Role of gangliosides in tumor progression
$372,530Stephan Ladisch · Children'S Research Institute · R01 · FY2011 · CA